Protein requirements and provision in hospitalised COVID-19 ward and ICU patients: Agreement between calculations based on body weight and height, and measured bioimpedance lean body mass

Moonen, Hanneke Pfx.; Hermans, Anoek J.H.; Jans, Inez; Zanten, A.R. van

doi:10.1016/j.clnesp.2022.03.001

Cited by 10 publications

(5 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…International guidelines have recently recommended assessing lean body mass (LBM) to determine protein goals in obese and overweight patients [4]. Several predictive formulas provide estimations of LBM) and can differ significantly from actual LBM [13 ▪ ]. LBM or muscle mass can be better estimated using Dual-energy X-ray absorptiometry, CT or MRI scans.…”

Section: Protein Provisionmentioning

confidence: 99%

Current insights in ICU nutrition: tailored nutrition

Hermans

Laarhuis²,

Kouw

et al. 2023

Current Opinion in Critical Care

View full text Add to dashboard Cite

Purpose of reviewTo summarize recent research on critical care nutrition focusing on the optimal composition, timing, and monitoring of enteral feeding strategies for (post)-ICU patients. We provide new insights on energy and protein recommendations, feeding intolerance, and describe nutritional practices for coronavirus disease 2019 ICU patients.Recent findingsThe use of indirect calorimetry to establish individual energy requirements for ICU patients is considered the gold standard. The limited research on optimal feeding targets in the early phase of critical illness suggests avoiding overfeeding. Protein provision based upon the absolute lean body mass is rational. Therefore, body composition measurements should be considered. Body impedance analysis and muscle ultrasound seem reliable, affordable, and accessible methods to assess body composition at the bedside. There is inadequate evidence to change our practice of continuous enteral feeding into intermittent feeding. Finally, severe acute respiratory syndrome coronavirus 2 patients are prone to underfeeding due to hypermetabolism and should be closely monitored.SummaryNutritional therapy should be adapted to the patient's characteristics, diagnosis, and state of metabolism during ICU stay and convalescence. A personalized nutrition plan may prevent harmful over- or underfeeding and attenuate muscle loss. Despite novel insights, more research is warranted into tailored nutrition strategies during critical illness and convalescence.

show abstract

Section: Protein Provisionmentioning

confidence: 99%

Current insights in ICU nutrition: tailored nutrition

Hermans

Laarhuis²,

Kouw

et al. 2023

Current Opinion in Critical Care

View full text Add to dashboard Cite

show abstract

“…108 A high protein diet may be beneficial for patients with COVID-19, as proteins may prevent further muscle protein breakdown for gluconeogenesis and protect patients from progressing to a further catabolic state. 109 Patients with COVID-19 admitted to the ICU often have higher protein requirements, and nutritional recommendations may vary between 1.2 and 2.5 g/kg/day of protein. 110,111 Vitamin D is essential for the maintenance of skeletal muscle health.…”

Section: Dovepressmentioning

confidence: 99%

Sarcopenia and COVID-19 Outcomes

Wang¹,

Tan²,

Yan³

et al. 2023

CIA

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) spread rapidly and became a severe global public health threat. Older adults have a high risk of COVID-19 and its associated mortality. Sarcopenia has emerged as a predictor of poor outcomes in COVID-19 patients, including lengthy hospital stays, mortality, intensive care unit admission, need for invasive mechanical ventilation, and poor rehabilitation outcomes. Chronic inflammation, immune dysfunction, respiratory muscle dysfunction, and swallowing dysfunction may underlie the association between sarcopenia and the poor outcomes of COVID-19 patients. Interleukin 6 receptor blockers (tocilizumab or sarilumab) are recommended for treating patients with severe COVID-19, and their therapeutic effects on sarcopenia are of great interest. This review aimed to analyze the current reports on the association between sarcopenia and COVID-19 and provide an update on the contribution of sarcopenia to the severity and adverse outcomes of COVID-19 and its underlying mechanisms. We also aimed to explore the different screening tools for sarcopenia concurrent with COVID-19, and advocate for early diagnosis and treatment of sarcopenia. Given that the fight against the COVID-19 pandemic may be long-term, further research into understanding the effects of sarcopenia in patients infected with the Omicron variant is necessary.

show abstract

“…Phenotyping involves identifying patient characteristics that may affect protein requirements, such as body mass index (BMI), sex, lean body mass (LBM), and age. Studies have shown that men generally require higher protein intake than women due to their larger body size and higher LBM [20]. However, in patients of the same sex and total body weight, variations in LBM can result in potential protein overfeeding or underfeeding.…”

Section: Individualised Protein Strategymentioning

confidence: 99%

Editorial: Personalized nutrition therapy in critical illness and convalescence: moving beyond one-size-fits-all to phenotyping and endotyping

Zanten

2023

Current Opinion in Critical Care

View full text Add to dashboard Cite

Protein requirements and provision in hospitalised COVID-19 ward and ICU patients: Agreement between calculations based on body weight and height, and measured bioimpedance lean body mass

Cited by 10 publications

References 21 publications

Current insights in ICU nutrition: tailored nutrition

Current insights in ICU nutrition: tailored nutrition

Sarcopenia and COVID-19 Outcomes

Editorial: Personalized nutrition therapy in critical illness and convalescence: moving beyond one-size-fits-all to phenotyping and endotyping

Contact Info

Product

Resources

About